Clinical Trial Update: L-arginine add-on Therapy in Patients With Schizophrenia [NA]

View source ↗

Summary

A clinical trial evaluating L-arginine as add-on therapy for schizophrenia and schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Hacettepe University | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED